India's Bold Leap: New Pharma Rules Set to Ignite R&D and Clinical Trials, Eyeing Global Leadership
The Unseen Engine of Medicine: Small Molecule API Market Poised for Explosive Growth
Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?
Trump's Trade Winds: Navigating the Storm for India's Pharma Giants
Trump's Bold Move: 100% Tariff on Branded Drugs Set to Shake Global Pharma, What It Means for India
Global Pharma Giants Set Sights on China: J&J and Roche Reportedly Eyeing Billion-Dollar Cancer Drug Deal with Henlius Biotech